Chronic suppression of a multidrug-resistant Pseudomonas aeruginosa in prosthetic joint infection using personalized

Rekha Arya1, Dongzhu Ma1, Jewelia J Rempuszewski1

  • 1Department of Orthopaedic Surgery, Bethel Musculoskeletal Research Center, Arthritis and Arthroplasty Design Lab, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Nature Communications
|June 27, 2026
PubMed

Insights

Bacteriophage therapy offers a novel treatment for multidrug-resistant (MDR) infections, particularly those linked to medical implants. This approach successfully resolved a severe Pseudomonas aeruginosa infection, demonstrating potential when antibiotics fail.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Biotechnology

Background:

  • Multidrug-resistant (MDR) bacterial infections pose a significant public health threat, especially in cases involving medical implants.
  • Conventional antibiotics are often ineffective against biofilms, which protect bacteria and contribute to persistent infections.
  • Pseudomonas aeruginosa periprosthetic joint infections are challenging to treat, often requiring extensive interventions.

Purpose of the Study:

  • To evaluate the efficacy of bacteriophage therapy as a standalone treatment for a MDR Pseudomonas aeruginosa periprosthetic joint infection.
  • To investigate the impact of bacteriophage therapy on infection virulence and biofilm structure.
  • To assess the long-term clinical and microbiological outcomes of bacteriophage therapy in a salvage case.

Main Methods:

  • A patient with a MDR Pseudomonas aeruginosa periprosthetic joint infection, unresponsive to antibiotics and surgery, received intermittent bacteriophage therapy over two years.
  • Whole genome sequencing was employed to monitor bacteriophage presence and potential genetic changes during treatment.
  • Clinical symptoms, disease severity, and biofilm characteristics were assessed to evaluate treatment response.

Main Results:

  • Bacteriophage therapy alone led to clinical resolution of the infection over the two-year treatment period.
  • While clinical symptoms improved, microbiological eradication of Pseudomonas aeruginosa was not achieved.
  • Bacteriophage therapy demonstrated an ability to alter bacterial virulence and disrupt biofilm formation.
  • Whole genome sequencing confirmed the sustained presence of bacteriophages throughout the treatment duration.

Conclusions:

  • Bacteriophage therapy presents a viable therapeutic option for managing MDR infections in salvage situations where conventional treatments are unavailable or have failed.
  • The therapy effectively controlled infection symptoms and virulence, highlighting its potential beyond direct bacterial killing.
  • Further research is warranted to optimize bacteriophage therapy protocols for complete microbiological eradication in chronic infections.

Related Concept Videos

Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...